Spots Global Cancer Trial Database for pain, intractable
Every month we try and update this database with for pain, intractable cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain | NCT02036281 | Terminally Ill Histologically-... Pain, Intractab... | Substance P-Sap... | 18 Years - | University of Texas Southwestern Medical Center | |
Study of the Impact of the Femoral Implant "Y-strut" on Lytic Bone Metastases of the Femoral Neck (WAZA-ARY) | NCT03887494 | Neoplasms, Bone... Pain, Intractab... Hip Fractures | Implantation | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
Effectiveness of Ketamine in Malignant Neuropathic Pain Relief | NCT01951911 | Pain, Intractab... | Ketamine Placebo | 18 Years - 70 Years | Haukeland University Hospital | |
Improving Outcomes and Lowering Costs by Integration of Primary Care Providers and Pain Medicine Physicians for Pain Pts | NCT02484937 | Back Pain Chronic Pain Pain, Intractab... | Group 2 (PCP Tr... Group 1 (PMS Tr... | 18 Years - | Rush University Medical Center | |
Efficacy and Safety of Ultra-low Dose Methadone as Adjuvant Analgesic in Cancer Patients With Pain | NCT02687347 | Pain, Intractab... | oral methadone oral morphine | 18 Years - 80 Years | McGill University Health Centre/Research Institute of the McGill University Health Centre | |
A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain | NCT02036281 | Terminally Ill Histologically-... Pain, Intractab... | Substance P-Sap... | 18 Years - | University of Texas Southwestern Medical Center | |
Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer | NCT05067257 | Pain, Intractab... Pain Cancer Pain | Resiniferatoxin Placebo | 18 Years - | Sorrento Therapeutics, Inc. | |
Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer | NCT05067257 | Pain, Intractab... Pain Cancer Pain | Resiniferatoxin Placebo | 18 Years - | Sorrento Therapeutics, Inc. | |
A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain | NCT02036281 | Terminally Ill Histologically-... Pain, Intractab... | Substance P-Sap... | 18 Years - | University of Texas Southwestern Medical Center | |
Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain | NCT04085120 | Cancer, Orophar... Pain, Intractab... Cancer Pain | 0.75 % Ropivaca... 10% lignocaine ... | 18 Years - | All India Institute of Medical Sciences, New Delhi | |
Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain | NCT04572776 | Pain, Intractab... Pain Cancer | Resiniferatoxin Standard of Car... | 18 Years - | Sorrento Therapeutics, Inc. | |
Post-market, Randomized, Controlled, Prospective Study Evaluating Intrathecal Pain Medication (IT) Versus Conventional Medical Management (CMM) in the Non-cancer, Refractory, Chronic Pain Population | NCT04096391 | Chronic Nonmali... Pain, Intractab... Pain, Chronic | Flowonix Promet... Pain Medicine | 22 Years - | Evolve Restorative Center |